| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Praxis Precision Medicines Inc (NASDAQ: PRAX)
PRAX Technical Analysis
5
| As on 17th Oct 2025 PRAX SHARE Price closed @ 189.99 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 58.91 & Strong Buy for SHORT-TERM with Stoploss of 45.36 we also expect STOCK to react on Following IMPORTANT LEVELS. |
PRAXSHARE Price
| Open | 178.90 | Change | Price | % |
| High | 203.57 | 1 Day | 27.28 | 16.77 |
| Low | 178.14 | 1 Week | 135.70 | 249.95 |
| Close | 189.99 | 1 Month | 143.14 | 305.53 |
| Volume | 4425000 | 1 Year | 135.12 | 246.25 |
| 52 Week High 90.77 | 52 Week Low 28.47 | ||||
NASDAQ USA Most Active Stocks
| AMRS | 0.14 | 100.00% |
| RANI | 1.64 | 248.94% |
| WBA | 11.98 | 0.50% |
| BYND | 0.65 | 25.00% |
| BITF | 5.01 | -5.11% |
| NVDA | 183.22 | 0.78% |
| LMDX | 0.02 | 0.00% |
| INTC | 37.01 | 0.46% |
| PLUG | 3.40 | -2.30% |
| AKTS | 0.04 | 0.00% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| PRAX Daily Charts |
PRAX Intraday Charts |
Whats New @ Bazaartrend |
PRAX Free Analysis |
|
|
PRAX Important Levels Intraday
| RESISTANCE | 238.99 |
| RESISTANCE | 223.28 |
| RESISTANCE | 213.56 |
| RESISTANCE | 203.85 |
| SUPPORT | 176.13 |
| SUPPORT | 166.42 |
| SUPPORT | 156.70 |
| SUPPORT | 140.99 |
PRAX Forecast October 2025
| 4th UP Forecast | 218.88 |
| 3rd UP Forecast | 209.61 |
| 2nd UP Forecast | 203.89 |
| 1st UP Forecast | 198.16 |
| 1st DOWN Forecast | 181.82 |
| 2nd DOWN Forecast | 176.09 |
| 3rd DOWN Forecast | 170.37 |
| 4th DOWN Forecast | 161.1 |
PRAX Weekly Forecast
| 4th UP Forecast | 210.26 |
| 3rd UP Forecast | 203.76 |
| 2nd UP Forecast | 199.74 |
| 1st UP Forecast | 195.72 |
| 1st DOWN Forecast | 184.26 |
| 2nd DOWN Forecast | 180.24 |
| 3rd DOWN Forecast | 176.22 |
| 4th DOWN Forecast | 169.72 |
PRAX Forecast2025
| 4th UP Forecast | 535.29 |
| 3rd UP Forecast | 424.55 |
| 2nd UP Forecast | 356.1 |
| 1st UP Forecast | 287.65 |
| 1st DOWN Forecast | 92.33 |
| 2nd DOWN Forecast | 23.88 |
| 3rd DOWN Forecast | -44.57 |
| 4th DOWN Forecast | -155.31 |
Praxis Precision Medicines Inc ( NASDAQ USA Symbol : PRAX )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
PRAX Business Profile
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of major depressive disorder and perimenopausal depression; and PRAX-944, a selective small molecule inhibitor of T-type calcium channels, which is in Phase IIa clinical trial for the treatment of essential tremor. The company is also developing PRAX-562, a persistent sodium current blocker that is in Phase I clinical trial to treat severe pediatric epilepsy and adult cephalgia; PRAX-222, an antisense oligonucleotide for patients with gain-of-function (GOF) SCN2A epilepsy; and KCNT1 program for the treatment of KCNT1 GOF epilepsy. It has a cooperation and license agreement with RogCon Inc.; a license agreement with Purdue Neuroscience Company; a research collaboration, option, and license agreement with Ionis Pharmaceuticals, Inc.; and collaboration with The Florey Institute to develop three novel ASOs. The company was incorporated in 2015 and is based in Cambridge, Massachusetts. Address: One Broadway, Cambridge, MA, United States, 02142
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service